Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes.

Rawat V, Wang S, Sima J, Bar R, Liraz O, Gundimeda U, Parekh T, Chan J, Johansson JO, Tang C, Chui HC, Harrington MG, Michaelson DM, Yassine HN.

J Neurosci. 2019 Nov 27;39(48):9611-9622. doi: 10.1523/JNEUROSCI.1400-19.2019. Epub 2019 Oct 22.

PMID:
31641056
2.

ApoE4 Exacerbates Hippocampal Pathology Following Acute Brain Penetration Injury in Female Mice.

Ben-Moshe H, Luz I, Liraz O, Boehm-Cagan A, Salomon-Zimri S, Michaelson D.

J Mol Neurosci. 2019 Sep 5. doi: 10.1007/s12031-019-01397-7. [Epub ahead of print] Review.

PMID:
31489583
3.

ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies.

Boehm-Cagan A, Bar R, Liraz O, Bielicki JK, Johansson JO, Michaelson DM.

J Alzheimers Dis. 2016 Oct 4;54(3):1219-1233.

PMID:
27567858
4.

Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.

Salomon-Zimri S, Glat MJ, Barhum Y, Luz I, Boehm-Cagan A, Liraz O, Ben-Zur T, Offen D, Michaelson DM.

J Alzheimers Dis. 2016 Jun 30;53(4):1443-58. doi: 10.3233/JAD-160182.

PMID:
27372644
5.

Behavioral testing affects the phenotypic expression of APOE ε3 and APOE ε4 in targeted replacement mice and reduces the differences between them.

Salomon-Zimri S, Liraz O, Michaelson DM.

Alzheimers Dement (Amst). 2015 Apr 15;1(2):127-35. doi: 10.1016/j.dadm.2014.11.014. eCollection 2015 Jun.

6.

An Anti-apoE4 Specific Monoclonal Antibody Counteracts the Pathological Effects of apoE4 In Vivo.

Luz I, Liraz O, Michaelson DM.

Curr Alzheimer Res. 2016 Jun 2;13(8):918-29.

PMID:
27040139
7.

The effects of the apoE4 genotype on the developing mouse retina.

Maharshak I, Salomon-Zimri S, Antes R, Liraz O, Nisgav Y, Livnat T, Weinberger D, Colton CA, Solomon AS, Michaelson DM.

Exp Eye Res. 2016 Apr;145:17-25. doi: 10.1016/j.exer.2015.11.001. Epub 2015 Nov 7.

PMID:
26554939
8.

Apolipoprotein E4 reduces evoked hippocampal acetylcholine release in adult mice.

Dolejší E, Liraz O, Rudajev V, Zimčík P, Doležal V, Michaelson DM.

J Neurochem. 2016 Feb;136(3):503-9. doi: 10.1111/jnc.13417. Epub 2015 Nov 19.

9.

Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo.

Gilat-Frenkel M, Boehm-Cagan A, Liraz O, Xian X, Herz J, Michaelson DM.

Curr Alzheimer Res. 2014;11(6):549-57.

10.

Hippocampus-related cognitive impairments in young apoE4 targeted replacement mice.

Salomon-Zimri S, Boehm-Cagan A, Liraz O, Michaelson DM.

Neurodegener Dis. 2014;13(2-3):86-92. doi: 10.1159/000354777. Epub 2013 Sep 24.

PMID:
24080852
11.

ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.

Liraz O, Boehm-Cagan A, Michaelson DM.

Mol Neurodegener. 2013 May 17;8:16. doi: 10.1186/1750-1326-8-16.

12.

Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up.

Lerner-Geva L, Rabinovici J, Olmer L, Blumstein T, Mashiach S, Lunenfeld B.

Gynecol Endocrinol. 2012 Oct;28(10):809-14. doi: 10.3109/09513590.2012.671391. Epub 2012 Apr 5. Erratum in: Gynecol Endocrinol. 2013 Apr;29(4):400. Liat, Lerner-Geva [corrected to Lerner-Geva, Liat]; Jaron, Rabinovici [corrected to Rabinovici, Jaron]; Liraz, Olmer [corrected to Olmer, Liraz]; Tzvia, Blumstein [corrected to Blumstein, Tzvia]; Shlomo, Mashiach [corrected to Mashiach, Shlomo]; Bruno, Lun.

PMID:
22475084
13.

The effects of apolipoproteins E3 and E4 on the transforming growth factor-β system in targeted replacement mice.

Haas A, Liraz O, Michaelson DM.

Neurodegener Dis. 2012;10(1-4):41-5. doi: 10.1159/000334902. Epub 2012 Feb 1.

PMID:
22301441
14.

CAMKII activation is not required for maintenance of learning-induced enhancement of neuronal excitability.

Liraz O, Rosenblum K, Barkai E.

PLoS One. 2009;4(1):e4289. doi: 10.1371/journal.pone.0004289. Epub 2009 Jan 28.

Supplemental Content

Support Center